Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01877070 · ClinicalTrials.gov registry record
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
A clinical trial of Low Risk Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 541
- Enrollment target
- 3
- Study locations
NCT01877070: Active study of Low Risk Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01877070 is a study of Low Risk Prostate Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 541 participants. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01877070, a study of Low Risk Prostate Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 541 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to collect information on how patients and their partners/close allies make treatment decisions when they have been diagnosed with early stage prostate cancer.
Primary Outcome
on the decision making process in men with prostate cancer who are eligible for active surveillance and their partners/close allies. All participants will be administered a set of questionnaires that assess psychological and affective functioning, and treatment preferences.
Conditions Studied
Interventions
- BEHAVIORAL assessments
Study Locations (3)
New York
- Memorial Sloan Kettering Westchester - Harrison
- Mount Sinai Hospital - New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2013-06 |
| Est. Completion | 2026-06 |
What the registry record for NCT01877070 still lists
NCT01877070 is an observational study that tracks outcomes without assigning an intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Low Risk Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which assessments is the first listed.
NCT01877070 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01877070 about?
NCT01877070 is a clinical study titled "Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies". The purpose of this study is to collect information on how patients and their partners/close allies make treatment decisions when they have been diagnosed with early stage prostate cancer.
What is the current status of trial NCT01877070?
This trial is currently active not recruiting. The enrollment target is 541 participants. The study started on 2013-06. Estimated completion is 2026-06.
What conditions does trial NCT01877070 study?
This clinical trial studies the following conditions: Low Risk Prostate Cancer.
What interventions are being tested in trial NCT01877070?
The interventions under investigation include: assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT01877070?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01877070 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia